| Autor: |
Laster AJ; Arthritis & Osteoporosis Consultants of the Carolinas, Charlotte, North Carolina, USA ajlaster@aocc.md., Lam GK; Arthritis & Osteoporosis Consultants of the Carolinas, Charlotte, North Carolina, USA., Gladue HS; Arthritis & Osteoporosis Consultants of the Carolinas, Charlotte, North Carolina, USA., Kashif AA; Arthritis & Osteoporosis Consultants of the Carolinas, Charlotte, North Carolina, USA., Siceloff EP; Arthritis & Osteoporosis Consultants of the Carolinas, Charlotte, North Carolina, USA., Lackey VD; Arthritis & Osteoporosis Consultants of the Carolinas, Charlotte, North Carolina, USA., Robertson CR; Arthritis & Osteoporosis Consultants of the Carolinas, Charlotte, North Carolina, USA., Toci AL; Arthritis & Osteoporosis Consultants of the Carolinas, Charlotte, North Carolina, USA., Calabrese LH; Rheumatology/Immunology, Cleveland Clinic, Cleveland, Ohio, USA. |
| Abstrakt: |
Competing Interests: Competing interests: AJL has the following relevant financial disclosures: consulting and speaking honoraria from Amgen, Lilly, Novartis, Pfizer, Roche/Genentech, Sanofi. GKL has the following relevant financial disclosures: consulting and speaking honoraria from Abbvie, Astra Zeneca, BMS, GSK, Horizon, Janssen, Pfizer, UCB. HSG has the following relevant financial disclosures: consulting and speaking honoraria from Astra Zeneca, GSK. LHC has the following relevant financial disclosures: consulting and speaking honoraria from Astra Zeneca, BMS, GSK, Janssen, Regeneron, Sanofi. |
